Thus, we postulated that the inhibition of the PTZ-induced TLR-4/NF-κB p65 signaling pathway activation in APS-treated mice could represent a pivotal mechanism for suppressing inflammation cytokine expression within the hippocampal tissues. Here, NFKB1 is linked to autoimmune polyendocrinopathy.